VSTM

Verastem, Inc. Press Releases

$7.44
*  
0.25
3.25%
Get VSTM Alerts
*Delayed - data as of Feb. 27, 2015  -  Find a broker to begin trading VSTM now
Exchange: NASDAQ
Industry: Health Care
Community Rating:
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save Stocks
Viewing
Filtered By
Ordered By
Verastem Receives Orphan Drug Designation from FDA for VS-5584 in Mesothelioma
2/12/2015 7:00:00 AM - Business Wire


Collegium Pharmaceutical Appoints Chief Financial Officer and New Member to its Board of Directors
2/9/2015 7:00:00 AM - eTeligis


Verastem Announces the Grant of Inducement Awards
2/5/2015 7:00:00 AM - Business Wire


Verastem to Present at Upcoming Investor Conferences
2/3/2015 7:00:00 AM - Business Wire


Verastem Announces Closing of $54 Million Public Offering of Common Stock and Exercise in Full of Underwriters’ Option to Purchase Additional Shares
1/29/2015 7:00:00 AM - Business Wire


Verastem Announces Pricing of Public Offering of Common Stock
1/22/2015 8:43:00 PM - Business Wire
▲6.29 % Price Change since this news event. The Volume Ratio is 6.97.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day


Verastem Announces Proposed Public Offering of Common Stock
1/20/2015 4:01:00 PM - Business Wire
▼-15.74 % Price Change since this news event. The Volume Ratio is 1.8.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day


Verastem Receives Orphan Medicinal Product Designation from the European Commission for VS-5584 in Mesothelioma
1/20/2015 8:00:00 AM - Business Wire
▼-11.74 % Price Change since this news event. The Volume Ratio is 0.82.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day


NovaBay Expands Sales Force for Avenova
1/20/2015 7:00:00 AM - Business Wire


Verastem Doses First Patient in Phase 1 Clinical Trial Evaluating VS-5584 in Combination with VS-6063 in Mesothelioma
1/20/2015 7:00:00 AM - Business Wire
▼-11.74 % Price Change since this news event. The Volume Ratio is 0.82.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day


Verastem Announces Publication of Scientific Data for VS-5584 in Cancer Research
1/16/2015 7:00:00 AM - Business Wire
▼-6.88 % Price Change since this news event. The Volume Ratio is 0.78.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day


Verastem Provides Year-End 2014 Update and Outlook for 2015
1/8/2015 4:01:00 PM - Business Wire
▼-19.04 % Price Change since this news event. The Volume Ratio is 1.13.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day


Verastem to Host Conference Call and Slide Webcast on Thursday, January 8 at 4:30pm ET
1/5/2015 4:01:00 PM - Business Wire
▼-20.68 % Price Change since this news event. The Volume Ratio is 0.66.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day


Verastem Appoints Daniel Paterson as Chief Operating Officer
12/18/2014 7:00:00 AM - Business Wire
▼-10.79 % Price Change since this news event. The Volume Ratio is 1.19.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day


Verastem Presents Data at the 2014 San Antonio Breast Cancer Symposium
12/11/2014 7:00:00 AM - Business Wire
▼-17.06 % Price Change since this news event. The Volume Ratio is 1.78.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day


Verastem Presents Data at the 2014 American Society of Hematology Annual Meeting
12/8/2014 10:30:00 AM - Business Wire
▼-20.51 % Price Change since this news event. The Volume Ratio is 0.62.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day


Verastem to Present Data at the 2014 San Antonio Breast Cancer Symposium
12/4/2014 7:00:00 AM - Business Wire
▼-20.77 % Price Change since this news event. The Volume Ratio is 0.55.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day


Verastem to Participate in Upcoming Investor Conferences
12/3/2014 7:00:00 AM - Business Wire
▼-20.77 % Price Change since this news event. The Volume Ratio is 0.64.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day